The FDA creates a quicker path for gene therapies
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first. The post The FDA creates a quicker path for gene therapies appeared first on TPR: The Public's Radio.
📰 Original Source
Read full article at Thepublicsradio →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.